ASP Isotopes (NASDAQ:ASPI) Trading Down 6.2% on Insider Selling

ASP Isotopes Inc. (NASDAQ:ASPI)’s stock price dropped 6.2% during mid-day trading on Monday following insider selling activity. The stock traded as low as $5.76 and last traded at $5.8370. Approximately 955,715 shares were traded during mid-day trading, a decline of 78% from the average daily volume of 4,396,342 shares. The stock had previously closed at $6.22.

Specifically, CEO Robert Ainscow sold 25,000 shares of ASP Isotopes stock in a transaction dated Tuesday, November 25th. The stock was sold at an average price of $5.77, for a total transaction of $144,250.00. Following the sale, the chief executive officer directly owned 1,554,693 shares of the company’s stock, valued at approximately $8,970,578.61. This trade represents a 1.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Paul Elliot Mann sold 50,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 25th. The shares were sold at an average price of $5.77, for a total transaction of $288,500.00. Following the completion of the transaction, the insider owned 7,921,691 shares of the company’s stock, valued at approximately $45,708,157.07. This trade represents a 0.63% decrease in their position. The SEC filing for this sale provides additional information. In related news, insider Paul Elliot Mann sold 112,500 shares of ASP Isotopes stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $7.51, for a total transaction of $844,875.00. Following the sale, the insider directly owned 7,971,691 shares in the company, valued at $59,867,399.41. This trade represents a 1.39% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Wall Street Analysts Forecast Growth

ASPI has been the subject of a number of research analyst reports. Canaccord Genuity Group reiterated a “buy” rating and issued a $11.00 target price on shares of ASP Isotopes in a report on Monday, November 24th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research report on Monday. Finally, Loop Capital set a $15.00 price objective on shares of ASP Isotopes in a research note on Monday, October 27th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, ASP Isotopes currently has an average rating of “Hold” and a consensus price target of $13.00.

ASP Isotopes Stock Performance

The business’s 50 day simple moving average is $8.96 and its two-hundred day simple moving average is $8.80. The firm has a market capitalization of $618.49 million, a PE ratio of -4.29 and a beta of 3.41. The company has a current ratio of 6.14, a quick ratio of 6.10 and a debt-to-equity ratio of 1.04.

ASP Isotopes (NASDAQ:ASPI) last issued its quarterly earnings data on Wednesday, November 19th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.05). ASP Isotopes had a negative return on equity of 190.44% and a negative net margin of 1,259.12%.The firm had revenue of $4.89 million during the quarter, compared to the consensus estimate of $2.25 million. Research analysts expect that ASP Isotopes Inc. will post -0.24 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Vanguard Group Inc. lifted its position in shares of ASP Isotopes by 37.9% in the third quarter. Vanguard Group Inc. now owns 4,516,763 shares of the company’s stock valued at $43,451,000 after acquiring an additional 1,241,024 shares in the last quarter. AWM Investment Company Inc. increased its holdings in ASP Isotopes by 6.2% in the 1st quarter. AWM Investment Company Inc. now owns 4,511,186 shares of the company’s stock valued at $21,157,000 after acquiring an additional 265,000 shares during the last quarter. Philadelphia Financial Management of San Francisco LLC lifted its stake in ASP Isotopes by 11.2% in the 1st quarter. Philadelphia Financial Management of San Francisco LLC now owns 3,508,062 shares of the company’s stock worth $16,453,000 after purchasing an additional 354,517 shares in the last quarter. Rovida Investment Management Ltd boosted its holdings in shares of ASP Isotopes by 45.5% during the 3rd quarter. Rovida Investment Management Ltd now owns 3,200,000 shares of the company’s stock valued at $30,688,000 after purchasing an additional 1,000,000 shares during the last quarter. Finally, Rovida Advisors Inc. purchased a new position in shares of ASP Isotopes during the second quarter valued at about $16,148,000. Hedge funds and other institutional investors own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.